Your immune system protects you from disease, but with autoimmune disease, the system attacks healthy cells resulting in chronic inflammation and any number of autoimmune diseases. On average it takes 5 doctors and 3.5 years to diagnose and autoimmune disease. This results in wasted time, disease progression and life changing damage. If not properly treated, and autoimmune disease can lead to lost productivity, disability and even death. According to the National Institutes of Health (NIH), the top 24 autoimmune diseases impact 23.5 million people in the United States and results in $127 billion a year in healthcare spend.
MedVerse helps physicians select a treatment option that is evidence-based with submission to the payer to obtain electronic preauthorization at the time of prescription so that patients can begin treatment without delay. The MedVerse platform provides advanced patient care by aligning the priorities of patients, physicians and payers at the moment of clinical prescribing. It is a win-win for providers and payers.
MedVerse is building an evidence-based medical library that is comprehensive, independent and non-biased. It includes evidence-based treatment regimens for autoimmune diseases. Regimens contain appropriate treatments for specific diseases, clinical outcome, and levels of medical evidence and support. It is a transformative decision-support solution with proven treatment plans and helps patients receive the highest quality evidence-based treatments available.
MedVerse helps physicians select a treatment option that is evidence-based with submission to the payer to obtain electronic preauthorization at the time of prescription so that patients can begin treatment without delay. We are developing an automated preauthorization tool to align the priorities of providers and payers and streamline administrative burden. This transparent treatment plan review and selection process streamlines workflow and reimbursement, reduces variability in clinical care, and results in cost efficiencies to benefit all participants in the autoimmune treatment process.
The MedVerse population health dashboard delivers reporting for physicians and care managers to assess and monitor the population by disease state, drive action and accountability, and quantify outcomes. It reports by autoimmune condition, prescribing patterns, treatment preferences, evidence-based guidelines, outcomes measures and trends. Output from analytics informs care management, care coordination and patient engagement.
According to the American College of Rheumatology ...05 September, 2018 Autoimmune Disease